These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 6420922)
1. Investigations of the lupus-like inhibitor by-passing activity of platelets. Howard MA; Firkin BG Thromb Haemost; 1983 Dec; 50(4):775-9. PubMed ID: 6420922 [TBL] [Abstract][Full Text] [Related]
2. Similar mechanism of various lupus anticoagulants. Exner T Thromb Haemost; 1985 Feb; 53(1):15-8. PubMed ID: 3922078 [TBL] [Abstract][Full Text] [Related]
3. The sensitivity of different coagulation reagents to the presence of lupus anticoagulants. Brandt JT; Triplett DA; Musgrave K; Orr C Arch Pathol Lab Med; 1987 Feb; 111(2):120-4. PubMed ID: 3101649 [TBL] [Abstract][Full Text] [Related]
4. Detection of procoagulant phospholipid interfering in tests for lupus anticoagulant. Exner T; Low J Thromb Res; 2004; 114(5-6):547-52. PubMed ID: 15507290 [TBL] [Abstract][Full Text] [Related]
5. A lupus anticoagulant neutralization procedure using the patient's own platelets. Carroll P; Ray M; Just S; Hawson G Blood Coagul Fibrinolysis; 1994 Aug; 5(4):523-7. PubMed ID: 7841308 [TBL] [Abstract][Full Text] [Related]
6. Evidence that von Willebrand factor is not required for the clotting of plasma in the presence of platelets and kaolin (Hardisty-Hutton test). McPherson J; Soberano ME; Macdonald C; Zucker MB Thromb Haemost; 1984 Apr; 51(2):272-4. PubMed ID: 6429885 [TBL] [Abstract][Full Text] [Related]
10. Correction of clotting factor "deficiencies" in plasma from patients with lupus-like anticoagulants. Clyne LP; Honig CL; Dainiak N Thromb Haemost; 1984 Jul; 51(3):317-20. PubMed ID: 6437003 [TBL] [Abstract][Full Text] [Related]
11. Comparison of two simple tests for the lupus anticoagulant. Exner T Am J Clin Pathol; 1985 Feb; 83(2):215-8. PubMed ID: 3918436 [TBL] [Abstract][Full Text] [Related]
12. A circulating lupus-like coagulation inhibitor induced by chlorpromazine. Tollefson G; Rodysill K; Cusulos M J Clin Psychopharmacol; 1984 Feb; 4(1):49-51. PubMed ID: 6420448 [TBL] [Abstract][Full Text] [Related]
13. The laboratory heterogeneity of lupus anticoagulants. Triplett DA; Brandt JT; Maas RL Arch Pathol Lab Med; 1985 Oct; 109(10):946-51. PubMed ID: 3929747 [TBL] [Abstract][Full Text] [Related]
14. The dilute phospholipid APTT: a sensitive assay for verification of lupus anticoagulants. Alving BM; Baldwin PE; Richards RL; Jackson BJ Thromb Haemost; 1985 Oct; 54(3):709-12. PubMed ID: 3937268 [TBL] [Abstract][Full Text] [Related]
15. The lupus inhibitor: a study of its heterogeneity. Coots MC; Miller MA; Glueck HI Thromb Haemost; 1981 Dec; 46(4):734-9. PubMed ID: 7330826 [TBL] [Abstract][Full Text] [Related]
16. Dysfibrinogenemia and lupus anticoagulant in a patient with recurrent thrombosis. Al-Mondhiry H; Galanakis D J Lab Clin Med; 1987 Dec; 110(6):726-33. PubMed ID: 3119749 [TBL] [Abstract][Full Text] [Related]
17. Plasma requirement for expression of lupus-like anticoagulant. Clyne LP Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):841-4. PubMed ID: 2436999 [TBL] [Abstract][Full Text] [Related]
18. Biological and clinical heterogeneity of lupus and lupus-like anticoagulant in fifty-seven patients. Horellou MH; Aurousseau MH; Boffa MC; Conrad J; Wiesel ML; Samama M J Med; 1987; 18(3-4):199-217. PubMed ID: 3480933 [TBL] [Abstract][Full Text] [Related]
19. [Idiopathic thrombocytopenic purpura complicated with circulating lupus anticoagulant]. Saito K; Ishiyama T; Hashimoto M; Osawa H; Koike M; Sugimoto M; Horie S; Wakabayashi Y; Hirose S Rinsho Ketsueki; 1990 Jan; 31(1):52-6. PubMed ID: 2107346 [TBL] [Abstract][Full Text] [Related]